AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
Keep up to date on AgNovos events and related news
AgNovos Healthcare will participate in the Osteologie Kongress in Frankfurt from March 28th - 30th .
Osteoporosis International recently published diagnosis and management guidance from ESCEO and IOF for postmenopausal women with osteoporosis. The publication marks the first time that Local Osteo-Enhancement Procedure has been recognized in this global treatment guidance document.
AgNovos Healthcare organized a Lunch Symposium in Berlin at DKOU with a panel of international orthopedic experts.
AgNovos Healthcare will participate in DKOU again this year in Berlin on October 23-26.
Dr. Christian Fang delivered a lecture at the Asia Pacific Orthopedics Association conference on April 10th in Antalya, Turkey.
As in 2016 and 2017, this year AgNovos is joining with ESCEO to present young Investigators with awards at the World Congress of Osteoporosis on Friday 20th April 10:20 am at Auditorium